INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $288,804 | +9.4% | 7,082 | 0.0% | 0.16% | +3.2% |
| Q1 2023 | $263,946 | +0.9% | 7,082 | -5.5% | 0.16% | -18.6% |
| Q4 2022 | $261,501 | -37.6% | 7,495 | 0.0% | 0.19% | -41.7% |
| Q3 2022 | $419,000 | +8.0% | 7,495 | 0.0% | 0.33% | +17.3% |
| Q2 2022 | $388,000 | -28.8% | 7,495 | 0.0% | 0.28% | -18.4% |
| Q1 2022 | $545,000 | -38.5% | 7,495 | 0.0% | 0.35% | -36.6% |
| Q4 2021 | $886,000 | -23.2% | 7,495 | -12.8% | 0.55% | -30.6% |
| Q3 2021 | $1,154,000 | -17.3% | 8,600 | -0.2% | 0.79% | -27.0% |
| Q2 2021 | $1,396,000 | +104.4% | 8,620 | +1.3% | 1.08% | +75.4% |
| Q1 2021 | $683,000 | +47.5% | 8,513 | 0.0% | 0.62% | +47.5% |
| Q4 2020 | $463,000 | – | 8,513 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |